We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Blood Screening Assay Approved in China and Brazil

By LabMedica International staff writers
Posted on 18 Nov 2010
An assay used in markets around the globe to screen donated blood for human immunodeficiency virus (HIV) Type 1 and Hepatitis viruses types B and C, has been granted approval for use in China and Brazil.

Sensitivity combined with the fully integrated and automated Procleix Ultrio assay, which is run on the TIGRIS platform, simplifies workflow and improves efficiency in the lab, a critical component to ensure testing and results are completed on time.

Novartis Diagnostics (Basel, Switzerland) launched the Procleix Ultrio assay and the Procleix TIGRIS platform in China at the Chinese Society of Blood Transfusion (CSBT) meeting, which took place on November 4-6, 2010, in Chengdu, China. More...
In Brazil, Novartis featured the Procleix Ultrio assay and the Procleix TIGRIS platform during the HEMO-Brazil meeting, which took place November 5-8, 2010, in Brasilia.

The company is working closely with blood centers in China and Brazil to introduce Ultrio and TIGRIS and help add an additional layer of blood safety to the blood screening process. In China, Novartis Diagnostics is collaborating with the Ministry of Health as part of the 2010 China nucleic acid testing (NAT) pilot program, sharing knowledge and best practices with blood centers using the Procleix Ultrio and TIGRIS systems to test NAT in their blood centers.

Blood screening centers in China and Brazil currently receive 10 million and 4.3 million annual blood donations, respectively. Blood centers in both countries are incorporating additional layers of protection to the blood screening process to increase the safety of the blood supply from donor to patient.

Related Links:

Novartis Diagnostics





Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Manual Pipetting Aid
Pipette Controllers macro
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image Credit: Adobe Stock

Immune Profiling Identifies Early Maternal Autoantibodies Linked to Preterm Birth Risk

A typical pregnancy lasts about 40 weeks, but labor begins prematurely in roughly one in 10 pregnancies. Preterm birth is the leading cause of newborn death worldwide, yet its underlying causes and which... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: Latest trends show that cancer diagnosis is evolving beyond a process focused mainly on medical imaging and microscopic tissue examination toward a more layered approach that incorporates molecular and genomic testing, liquid biopsy, digital pathology, and AI (Image Credit: iStock)

Expanding Screening and Biomarker Testing Drive Cancer Diagnostics Market Growth

Cancer diagnostics encompasses imaging, tissue pathology, laboratory testing, and molecular technologies used to detect, confirm, characterize, and monitor cancer. The global cancer diagnostics market... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.